{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:26:41Z","timestamp":1789165601681,"version":"build-2803163510"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s12035-025-04750-7","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T05:44:05Z","timestamp":1740548645000},"page":"8502-8517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Role of MicroRNAs in Neurodegeneration: Insights from Huntington\u2019s Disease"],"prefix":"10.1007","volume":"62","author":[{"given":"Reda M.","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abanoub A. S.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed I.","family":"Abulsoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif S. Abdel","family":"Mageed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsayed G. E.","family":"Elsakka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed. I.","family":"Dahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Sadek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah A.","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radwa H.","family":"Lutfy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Elimam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed H. I.","family":"Faraag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara A.","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7728-0923","authenticated-orcid":false,"given":"Mustafa Ahmed","family":"Abdel-Reheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0136-7096","authenticated-orcid":false,"given":"Ahmed S.","family":"Doghish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"issue":"9","key":"4750_CR1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mds.25075","volume":"27","author":"T Pringsheim","year":"2012","unstructured":"Pringsheim T, Wiltshire K, Day L, Dykeman J, Steeves T, Jette N (2012) The incidence and prevalence of huntington\u2019s disease: A systematic review and meta-analysis. Mov Disord 27(9):1083\u20131091","journal-title":"Mov Disord"},{"issue":"12","key":"4750_CR2","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/mds.29228","volume":"37","author":"A Medina","year":"2022","unstructured":"Medina A, Mahjoub Y, Shaver L, Pringsheim T (2022) Prevalence and incidence of huntington\u2019s disease: An updated systematic review and meta-analysis. Mov Disord 37(12):2327\u20132335","journal-title":"Mov Disord"},{"key":"4750_CR3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/B978-0-12-801893-4.00003-1","volume":"144","author":"C Kay","year":"2017","unstructured":"Kay C, Hayden MR, Leavitt BR (2017) Epidemiology of Huntington disease. Handb Clin Neurol 144:31\u201346","journal-title":"Handb Clin Neurol"},{"key":"4750_CR4","doi-asserted-by":"crossref","first-page":"705348","DOI":"10.3389\/fncel.2021.705348","volume":"15","author":"X Dong","year":"2021","unstructured":"Dong X, Cong S (2021) MicroRNAs in Huntington\u2019s disease: diagnostic biomarkers or therapeutic agents? Front Cell Neurosci 15:705348","journal-title":"Front Cell Neurosci"},{"issue":"10","key":"4750_CR5","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3390\/brainsci12101389","volume":"12","author":"Z Irfan","year":"2022","unstructured":"Irfan Z, Khanam S, Karmakar V, Firdous SM, El Khier BSIA, Khan I, Rehman MU, Khan A (2022) Pathogenesis of huntington\u2019s disease: An emphasis on molecular pathways and prevention by natural remedies. Brain Sci 12(10):1389","journal-title":"Brain Sci"},{"key":"4750_CR6","first-page":"1","volume":"2013","author":"G Ellrichmann","year":"2013","unstructured":"Ellrichmann G, Reick C, Saft C, Linker RA (2013) The role of the immune system in Huntington\u2019s disease. J Immu Res 2013:1\u201311","journal-title":"J Immu Res"},{"issue":"9","key":"4750_CR7","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.3390\/ijms23094718","volume":"23","author":"TPN Nguyen","year":"2022","unstructured":"Nguyen TPN, Kumar M, Fedele E, Bonanno G, Bonifacino T (2022) MicroRNA alteration, application as biomarkers, and therapeutic approaches in neurodegenerative diseases. Int J Mol Sci 23(9):4718","journal-title":"Int J Mol Sci"},{"key":"4750_CR8","unstructured":"Bruyn GW (1968) Handbook of clinical neurology, vol 87. North 4, Amsterdam, pp 1\u201323"},{"key":"4750_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-5-1","volume":"5","author":"RAC Roos","year":"2010","unstructured":"Roos RAC (2010) Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis 5:1\u20138","journal-title":"Orphanet J Rare Dis"},{"key":"4750_CR10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.conb.2015.01.020","volume":"33","author":"JL Plotkin","year":"2015","unstructured":"Plotkin JL, Surmeier DJ (2015) Corticostriatal synaptic adaptations in Huntington\u2019s disease. Curr Opin Neurobiol 33:53\u201362","journal-title":"Curr Opin Neurobiol"},{"issue":"12","key":"4750_CR11","first-page":"1520","volume":"70","author":"ER Dorsey","year":"2013","unstructured":"Dorsey ER, Beck CA, Darwin K, Nichols P, Brocht AFD, Biglan KM, Shoulson I, C.I. Huntington Study Group (2013) Natural history of huntington disease. JAMA neurology 70(12):1520\u20131530","journal-title":"JAMA neurology"},{"issue":"7","key":"4750_CR12","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/01.wnl.0000204230.16619.d9","volume":"66","author":"A Rosenblatt","year":"2006","unstructured":"Rosenblatt A, Liang KY, Zhou H, Abbott MH, Gourley LM, Margolis RL, Brandt J, Ross CA (2006) The association of CAG repeat length with clinical progression in Huntington disease. Neurology 66(7):1016\u20131020","journal-title":"Neurology"},{"issue":"5","key":"4750_CR13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/mds.25864","volume":"29","author":"M Papoutsi","year":"2014","unstructured":"Papoutsi M, Labuschagne I, Tabrizi SJ, Stout JC (2014) The cognitive burden in Huntington\u2019s disease: pathology, phenotype, and mechanisms of compensation. Mov Disord 29(5):673\u2013683","journal-title":"Mov Disord"},{"issue":"4","key":"4750_CR14","first-page":"219","volume":"14","author":"D Craufurd","year":"2001","unstructured":"Craufurd D, Thompson JC, Snowden JS (2001) Behavioral changes in Huntington disease. Cogn Behav Neurol 14(4):219\u2013226","journal-title":"Cogn Behav Neurol"},{"issue":"9","key":"4750_CR15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RAC, Durr A, Craufurd D, Kennard C, Hicks SL et al (2009) Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. The Lancet Neurology 8(9):791\u2013801","journal-title":"The Lancet Neurology"},{"key":"4750_CR16","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/jnnp-2013-307343","volume":"85","author":"E Van Duijn","year":"2014","unstructured":"Van Duijn E, Craufurd D, Hubers AA, Giltay EJ, Bonelli R, Rickards H, Anderson KE, van Walsem MR et al (2014) Neuropsychiatric symptoms in a European Huntington\u2019s disease cohort (Registry). J Neurol Neurosurg Psychiatry 85:1411\u20131418","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4750_CR17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-444-52014-2.00001-X","volume":"100","author":"KM Shannon","year":"2011","unstructured":"Shannon KM (2011) Huntington\u2019s disease\u2013clinical signs, symptoms, presymptomatic diagnosis, and diagnosis. Handb Clin Neurol 100:3\u201313","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"4750_CR18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/practneurol-2013-000790","volume":"15","author":"D Craufurd","year":"2015","unstructured":"Craufurd D, MacLeod R, Frontali M, Quarrell O, Bijlsma EK, Davis M, Hjermind LE, Lahiri N et al (2015) Diagnostic genetic testing for Huntington\u2019s disease. Pract Neurol 15(1):80\u201384","journal-title":"Pract Neurol"},{"issue":"7","key":"4750_CR19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/jnnp-2011-301940","volume":"83","author":"JC Stout","year":"2012","unstructured":"Stout JC, Jones R, Labuschagne I, O\u2019Regan AM, Say MJ, Dumas EM, Queller S, Justo D et al (2012) Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 83(7):687\u2013694","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"4750_CR20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","volume":"11","author":"SJ Tabrizi","year":"2012","unstructured":"Tabrizi SJ, Reilmann R, Roos RAC, Durr A, Leavitt B, Owen G, Jones R, Johnson H et al (2012) Potential endpoints for clinical trials in premanifest and early Huntington\u2019s disease in the TRACK-HD study: analysis of 24 month observational data. The Lancet Neurology 11(1):42\u201353","journal-title":"The Lancet Neurology"},{"issue":"7","key":"4750_CR21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","volume":"12","author":"SJ Tabrizi","year":"2013","unstructured":"Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B et al (2013) Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: analysis of 36-month observational data. The Lancet Neurology 12(7):637\u2013649","journal-title":"The Lancet Neurology"},{"issue":"8","key":"4750_CR22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1474-4422(17)30124-2","volume":"16","author":"LM Byrne","year":"2017","unstructured":"Byrne LM, Rodrigues FB, Blennow K, Durr A, Leavitt BR, Roos RAC, Scahill RI, Tabrizi SJ et al (2017) Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington\u2019s disease: a retrospective cohort analysis. The Lancet Neurology 16(8):601\u2013609","journal-title":"The Lancet Neurology"},{"issue":"1","key":"4750_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JHD-160196","volume":"5","author":"LM Byrne","year":"2016","unstructured":"Byrne LM, Wild EJ (2016) Cerebrospinal fluid biomarkers for Huntington\u2019s disease. Journal of Huntington\u2019s disease 5(1):1\u201313","journal-title":"Journal of Huntington\u2019s disease"},{"issue":"5","key":"4750_CR24","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1172\/JCI80743","volume":"125","author":"EJ Wild","year":"2015","unstructured":"Wild EJ, Boggio R, Langbehn D, Robertson N, Haider S, Miller JRC, Zetterberg H, Leavitt BR et al (2015) Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington\u2019s disease patients. J Clin Investig 125(5):1979\u20131986","journal-title":"J Clin Investig"},{"issue":"1","key":"4750_CR25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ (2018) Huntington\u2019s disease: a clinical review. Eur J Neurol 25(1):24\u201334","journal-title":"Eur J Neurol"},{"issue":"10","key":"4750_CR26","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.embor.7400250","volume":"5","author":"C Landles","year":"2004","unstructured":"Landles C, Bates GP (2004) Huntingtin and the molecular pathogenesis of huntington\u2019s disease: Fourth in molecular medicine review series. EMBO Rep 5(10):958\u2013963","journal-title":"EMBO Rep"},{"issue":"5576","key":"4750_CR27","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","volume":"296","author":"AW Dunah","year":"2002","unstructured":"Dunah AW, Jeong H, Griffin A, Kim Y-M, Standaert DG, Hersch SM, Mouradian MM, Young AB et al (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington\u2019s disease. Science 296(5576):2238\u20132243","journal-title":"Science"},{"key":"4750_CR28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fnmol.2018.00153","volume":"11","author":"C Xiang","year":"2018","unstructured":"Xiang C, Zhang S, Dong X, Ma S, Cong S (2018) Transcriptional dysregulation and post-translational modifications in polyglutamine diseases: from pathogenesis to potential therapeutic strategies. Front Mol Neurosci 11:153","journal-title":"Front Mol Neurosci"},{"issue":"6857","key":"4750_CR29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","volume":"413","author":"JS Steffan","year":"2001","unstructured":"Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, Kazantsev A, Schmidt E et al (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413(6857):739\u2013743","journal-title":"Nature"},{"issue":"6","key":"4750_CR30","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","volume":"11","author":"S Bathina","year":"2015","unstructured":"Bathina S, Das UN (2015) Brain-derived neurotrophic factor and its clinical implications. Archives of medical science\u202f: AMS 11(6):1164\u20131178","journal-title":"Archives of medical science : AMS"},{"key":"4750_CR31","doi-asserted-by":"crossref","first-page":"834620","DOI":"10.3389\/fcell.2022.834620","volume":"10","author":"XJ Su","year":"2022","unstructured":"Su XJ, Shen BD, Wang K, Song QX, Yang X, Wu DS, Shen HX, Zhu C (2022) Roles of the Neuron-Restrictive Silencer Factor in the Pathophysiological Process of the Central Nervous System. Frontiers in Cell and Developmental Biology 10:834620","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"4750_CR32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.conb.2017.12.008","volume":"48","author":"J-Y Hwang","year":"2018","unstructured":"Hwang J-Y, Zukin RS (2018) REST, a master transcriptional regulator in neurodegenerative disease. Curr Opin Neurobiol 48:193\u2013200","journal-title":"Curr Opin Neurobiol"},{"issue":"10","key":"4750_CR33","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1007\/s12035-023-03437-1","volume":"60","author":"A Nassar","year":"2023","unstructured":"Nassar A, Satarker S, Gurram PC, Upadhya D, Fayaz SM, Nampoothiri M (2023) Repressor element-1 binding transcription factor (REST) as a possible epigenetic regulator of neurodegeneration and microrna-based therapeutic strategies. Mol Neurobiol 60(10):5557\u20135577","journal-title":"Mol Neurobiol"},{"issue":"7","key":"4750_CR34","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/77565","volume":"6","author":"P Lawinger","year":"2000","unstructured":"Lawinger P, Venugopal R, Guo Z-S, Immaneni A, Sengupta D, Lu W, Rastelli L, Marin Dias Carneiro A et al (2000) The neuronal repressor REST\/NRSF is an essential regulator in medulloblastoma cells. Nat med 6(7):826\u2013831","journal-title":"Nat med"},{"issue":"1","key":"4750_CR35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrn1587","volume":"6","author":"PJ Muchowski","year":"2005","unstructured":"Muchowski PJ, Wacker JL (2005) Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6(1):11\u201322","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"4750_CR36","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.chembiol.2021.04.003","volume":"28","author":"F T\u00fcrker","year":"2021","unstructured":"T\u00fcrker F, Cook EK, Margolis SS (2021) The proteasome and its role in the nervous system. Cell Chem Biol 28(7):903\u2013917","journal-title":"Cell Chem Biol"},{"issue":"3","key":"4750_CR37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1566-2772(03)00056-2","volume":"3","author":"B Ravikumar","year":"2003","unstructured":"Ravikumar B, Sarkar S, Berger Z, Rubinsztein DC (2003) The roles of the ubiquitin-proteasome and autophagy\u2013lysosome pathways in Huntington\u2019s disease and related conditions. Clin Neurosci Res 3(3):141\u2013148","journal-title":"Clin Neurosci Res"},{"issue":"12","key":"4750_CR38","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nsmb860","volume":"11","author":"JL Wacker","year":"2004","unstructured":"Wacker JL, Zareie MH, Fong H, Sarikaya M, Muchowski PJ (2004) Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer. Nat Struct Mol Biol 11(12):1215\u20131222","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"4750_CR39","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0896-6273(03)00606-8","volume":"40","author":"A Ciechanover","year":"2003","unstructured":"Ciechanover A, Brundin P (2003) The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40(2):427\u2013446","journal-title":"Neuron"},{"issue":"1","key":"4750_CR40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1242\/dev.094805","volume":"141","author":"K Mendelson","year":"2014","unstructured":"Mendelson K, Evans T, Hla T (2014) Sphingosine 1-phosphate signalling. Development 141(1):5\u20139","journal-title":"Development"},{"key":"4750_CR41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fphar.2020.00077","volume":"11","author":"\u00c9 P\u00e9pin","year":"2020","unstructured":"P\u00e9pin \u00c9, Jalinier T, Lemieux GL, Massicotte G, Cyr M (2020) Sphingosine-1-Phosphate Receptors Modulators Decrease Signs of Neuroinflammation and Prevent Parkinson\u2019s Disease Symptoms in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model. Front Pharmacol 11:77","journal-title":"Front Pharmacol"},{"issue":"9,Part B","key":"4750_CR42","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bbamem.2017.03.008","volume":"1859","author":"I Karunakaran","year":"2017","unstructured":"Karunakaran I, van Echten-Deckert G (2017) Sphingosine 1-phosphate \u2013 A double edged sword in the brain. Biochimica et Biophysica Acta (BBA) - Biomembranes 1859(9,Part B):1573\u20131582","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"key":"4750_CR43","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.3389\/fphys.2019.01531","volume":"10","author":"G Qi","year":"2020","unstructured":"Qi G, Mi Y, Yin F (2020) Cellular specificity and inter-cellular coordination in the brain bioenergetic system: Implications for aging and neurodegeneration. Front Physiol 10:1531","journal-title":"Front Physiol"},{"key":"4750_CR44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-319-71779-1_3","volume-title":"Polyglutamine Disorders","author":"C Carmo","year":"2018","unstructured":"Carmo C, Naia L, Lopes C, Rego AC (2018) Mitochondrial dysfunction in huntington\u2019s disease. In: N\u00f3brega C, Pereira De Almeida L (eds) Polyglutamine Disorders. Springer International Publishing, Cham, pp 59\u201383"},{"issue":"1","key":"4750_CR45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1212\/WNL.28.1.23","volume":"28","author":"HH Goebel","year":"1978","unstructured":"Goebel HH, Heipertz R, Scholz W, Iqbal K, Tellez-Nagel I (1978) Juvenile huntington chorea: Clinical, ultrastructural, and biochemical studies. Neurology 28(1):23\u201323","journal-title":"Neurology"},{"issue":"1","key":"4750_CR46","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12035-014-8735-4","volume":"51","author":"L Naia","year":"2015","unstructured":"Naia L, Ferreira IL, Cunha-Oliveira T, Duarte AI, Ribeiro M, Rosenstock TR, La\u00e7o MN, Ribeiro MJ et al (2015) Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in huntington\u2019s disease human lymphoblasts. Mol Neurobiol 51(1):331\u2013348","journal-title":"Mol Neurobiol"},{"issue":"6","key":"4750_CR47","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1471-4159.2005.03036.x","volume":"93","author":"N Brustovetsky","year":"2005","unstructured":"Brustovetsky N, LaFrance R, Purl KJ, Brustovetsky T, Keene CD, Low WC, Dubinsky JM (2005) Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of huntington\u2019s disease. J Neurochem 93(6):1361\u20131370","journal-title":"J Neurochem"},{"issue":"19","key":"4750_CR48","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1093\/hmg\/ddi319","volume":"14","author":"IS Seong","year":"2005","unstructured":"Seong IS, Ivanova E, Lee J-M, Choo YS, Fossale E, Anderson M, Gusella JF, Laramie JM et al (2005) HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. Hum Mol Genet 14(19):2871\u20132880","journal-title":"Hum Mol Genet"},{"issue":"4","key":"4750_CR49","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000321681","volume":"8","author":"SF Zhang","year":"2011","unstructured":"Zhang SF, Hennessey T, Yang L, Starkova NN, Beal MF, Starkov AA (2011) Impaired brain creatine kinase activity in huntington\u2019s disease. Neurodegener Dis 8(4):194\u2013201","journal-title":"Neurodegener Dis"},{"issue":"1","key":"4750_CR50","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.expneurol.2011.05.024","volume":"231","author":"IL Ferreira","year":"2011","unstructured":"Ferreira IL, Cunha-Oliveira T, Nascimento MV, Ribeiro M, Proen\u00e7a MT, Janu\u00e1rio C, Oliveira CR, Rego AC (2011) Bioenergetic dysfunction in Huntington\u2019s disease human cybrids. Exp Neurol 231(1):127\u2013134","journal-title":"Exp Neurol"},{"issue":"1","key":"4750_CR51","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.1085","volume":"50","author":"OA Andreassen","year":"2001","unstructured":"Andreassen OA, Ferrante RJ, Huang HM, Dedeoglu A, Park L, Ferrante KL, Kwon J, Borchelt DR et al (2001) Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington\u2019s disease. Ann Neurol 50(1):112\u2013116","journal-title":"Ann Neurol"},{"issue":"4","key":"4750_CR52","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1091\/mbc.e05-07-0607","volume":"17","author":"A Benchoua","year":"2006","unstructured":"Benchoua A, Trioulier Y, Zala D, Gaillard M-C, Lefort N, Dufour N, Saudou F, Elalouf J-M et al (2006) Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin. MBoC 17(4):1652\u20131663","journal-title":"MBoC"},{"issue":"1\u20134","key":"4750_CR53","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000072864","volume":"100","author":"A Sawa","year":"2003","unstructured":"Sawa A, Tomoda T, Bae BI (2003) Mechanisms of neuronal cell death in Huntington\u2019s disease. Cytogenet Genome Res 100(1\u20134):287\u2013295","journal-title":"Cytogenet Genome Res"},{"key":"4750_CR54","first-page":"65","volume":"5","author":"J Schulte","year":"2011","unstructured":"Schulte J, Littleton JT (2011) The biological function of the Huntingtin protein and its relevance to huntington\u2019s disease pathology. Curr Trends Neurol 5:65\u201378","journal-title":"Curr Trends Neurol"},{"issue":"1","key":"4750_CR55","doi-asserted-by":"crossref","first-page":"22137","DOI":"10.1038\/s41598-020-78790-5","volume":"10","author":"V Fodale","year":"2020","unstructured":"Fodale V, Pintauro R, Daldin M, Altobelli R, Spiezia MC, Bisbocci M, Macdonald D, Bresciani A (2020) Analysis of mutant and total huntingtin expression in Huntington\u2019s disease murine models. Sci Rep 10(1):22137","journal-title":"Sci Rep"},{"issue":"10","key":"4750_CR56","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/13518","volume":"5","author":"A Sawa","year":"1999","unstructured":"Sawa A, Wiegand GW, Cooper J, Margolis RL, Sharp AH, Lawler JF, Greenamyre JT, Snyder SH et al (1999) Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat Med 5(10):1194\u20131198","journal-title":"Nat Med"},{"issue":"19","key":"4750_CR57","doi-asserted-by":"crossref","first-page":"7268","DOI":"10.1523\/JNEUROSCI.20-19-07268.2000","volume":"20","author":"KB Kegel","year":"2000","unstructured":"Kegel KB, Kim M, Sapp E, McIntyre C, Casta\u00f1o JG, Aronin N, DiFiglia M (2000) Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy. J Neurosci 20(19):7268\u20137278","journal-title":"J Neurosci"},{"issue":"9","key":"4750_CR58","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/hmg\/11.9.1107","volume":"11","author":"B Ravikumar","year":"2002","unstructured":"Ravikumar B (2002) Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet 11(9):1107\u20131117","journal-title":"Hum Mol Genet"},{"issue":"1","key":"4750_CR59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/mcne.2000.0909","volume":"17","author":"MM Zeron","year":"2001","unstructured":"Zeron MM, Chen N, Moshaver A, Ting-Chun Lee A, Wellington CL, Hayden MR, Raymond LA (2001) Mutant huntingtin enhances excitotoxic cell death. Mole Cellular Neuroscience 17(1):41\u201353","journal-title":"Mole Cellular Neuroscience"},{"issue":"6","key":"4750_CR60","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","volume":"33","author":"MM Zeron","year":"2002","unstructured":"Zeron MM, Hansson O, Chen N, Wellington CL, Leavitt BR, Brundin P, Hayden MR, Raymond LA (2002) Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of huntington\u2019s disease. Neuron 33(6):849\u2013860","journal-title":"Neuron"},{"issue":"1","key":"4750_CR61","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1073858420972662","volume":"28","author":"C Cepeda","year":"2022","unstructured":"Cepeda C, Levine MS (2022) Synaptic dysfunction in Huntington\u2019s disease: lessons from genetic animal models. Neuroscientist 28(1):20\u201340","journal-title":"Neuroscientist"},{"issue":"4","key":"4750_CR62","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/brain\/awq047","volume":"133","author":"DCV Thu","year":"2010","unstructured":"Thu DCV, Oorschot DE, Tippett LJ, Nana AL, Hogg VM, Synek BJ, Luthi-Carter R, Waldvogel HJ et al (2010) Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington\u2019s disease. Brain 133(4):1094\u20131110","journal-title":"Brain"},{"issue":"23","key":"4750_CR63","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1523\/JNEUROSCI.21-23-09112.2001","volume":"21","author":"GA Laforet","year":"2001","unstructured":"Laforet GA, Sapp E, Chase K, McIntyre C, Boyce FM, Campbell M, Cadigan BA, Warzecki L et al (2001) Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington\u2019s disease. J Neurosci 21(23):9112\u20139123","journal-title":"J Neurosci"},{"issue":"19","key":"4750_CR64","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/hmg\/ddl224","volume":"15","author":"DM Cummings","year":"2006","unstructured":"Cummings DM, Milnerwood AJ, Dallerac GM, Waights V, Brown JY, Vatsavayai SC, Hirst MC, Murphy KPSJ (2006) Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington\u2019s disease. Hum Mol Genet 15(19):2856\u20132868","journal-title":"Hum Mol Genet"},{"issue":"1","key":"4750_CR65","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neuron.2016.11.035","volume":"93","author":"M Barnat","year":"2017","unstructured":"Barnat M, Le Friec J, Benstaali C, Humbert S (2017) Huntingtin-mediated multipolar-bipolar transition of newborn cortical neurons is critical for their postnatal neuronal morphology. Neuron 93(1):99\u2013114","journal-title":"Neuron"},{"key":"4750_CR66","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.nbd.2016.09.006","volume":"96","author":"EE Arteaga-Bracho","year":"2016","unstructured":"Arteaga-Bracho EE, Gulinello M, Winchester ML, Pichamoorthy N, Petronglo JR, Zambrano AD, Inocencio J, De Jesus CD et al (2016) Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington\u2019s disease. Neurobiol Dis 96:144\u2013155","journal-title":"Neurobiol Dis"},{"key":"4750_CR67","volume-title":"lnvestigating the role of microglia and the immune system in huntington\u2019s disease","author":"W Kwan","year":"2011","unstructured":"Kwan W (2011) lnvestigating the role of microglia and the immune system in huntington\u2019s disease. University of California, San Francisco"},{"issue":"3","key":"4750_CR68","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/brain\/awt355","volume":"137","author":"U Tr\u00e4ger","year":"2014","unstructured":"Tr\u00e4ger U, Andre R, Lahiri N, Magnusson-Lind A, Weiss A, Grueninger S, McKinnon C, Sirinathsinghji E et al (2014) HTT-lowering reverses Huntington\u2019s disease immune dysfunction caused by NF\u03baB pathway dysregulation. Brain 137(3):819\u2013833","journal-title":"Brain"},{"issue":"50","key":"4750_CR69","doi-asserted-by":"crossref","first-page":"18259","DOI":"10.1523\/JNEUROSCI.4008-12.2012","volume":"32","author":"J Bouchard","year":"2012","unstructured":"Bouchard J, Truong J, Bouchard K, Dunkelberger D, Desrayaud S, Moussaoui S, Tabrizi SJ, Stella N et al (2012) Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington\u2019s disease. J Neurosci 32(50):18259\u201318268","journal-title":"J Neurosci"},{"issue":"12","key":"4750_CR70","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1172\/JCI64484","volume":"122","author":"W Kwan","year":"2012","unstructured":"Kwan W, Tr\u00e4ger U, Davalos D, Chou A, Bouchard J, Andre R, Miller A, Weiss A et al (2012) Mutant huntingtin impairs immune cell migration in Huntington disease. J Clin Investig 122(12):4737\u20134747","journal-title":"J Clin Investig"},{"issue":"1","key":"4750_CR71","doi-asserted-by":"crossref","first-page":"20477","DOI":"10.1038\/s41598-023-46852-z","volume":"13","author":"N St\u00f6berl","year":"2023","unstructured":"St\u00f6berl N, Donaldson J, Binda CS, McAllister B, Hall-Roberts H, Jones L, Massey TH, Allen ND (2023) Mutant huntingtin confers cell-autonomous phenotypes on Huntington\u2019s disease iPSC-derived microglia. Sci Rep 13(1):20477","journal-title":"Sci Rep"},{"issue":"12","key":"4750_CR72","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.3390\/cells11121979","volume":"11","author":"J Austermann","year":"2022","unstructured":"Austermann J, Roth J, Barczyk-Kahlert K (2022) The good and the bad: Monocytes\u2019 and macrophages\u2019 diverse functions in inflammation. Cells 11(12):1979","journal-title":"Cells"},{"issue":"8","key":"4750_CR73","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3390\/cells11081327","volume":"11","author":"S Kiran","year":"2022","unstructured":"Kiran S, Rakib A, Kodidela S, Kumar S, Singh UP (2022) High-fat diet-induced dysregulation of immune cells correlates with macrophage phenotypes and chronic inflammation in adipose tissue. Cells 11(8):1327","journal-title":"Cells"},{"issue":"7","key":"4750_CR74","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/awab103","volume":"144","author":"GP Williams","year":"2021","unstructured":"Williams GP, Schonhoff AM, Jurkuvenaite A, Gallups NJ, Standaert DG, Harms AS (2021) CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease. Brain 144(7):2047\u20132059","journal-title":"Brain"},{"issue":"13","key":"4750_CR75","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.3390\/jcm11133759","volume":"11","author":"S Campo","year":"2022","unstructured":"Campo S, Lacquaniti A, Trombetta D, Smeriglio A, Monardo P (2022) Immune system dysfunction and inflammation in hemodialysis patients: two sides of the same coin. J Clin Med 11(13):3759","journal-title":"J Clin Med"},{"issue":"10","key":"4750_CR76","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.3390\/ijms21103422","volume":"21","author":"V Losappio","year":"2020","unstructured":"Losappio V, Franzin R, Infante B, Godeas G, Gesualdo L, Fersini A, Castellano G, Stallone G (2020) Molecular mechanisms of premature aging in hemodialysis: the complex interplay between innate and adaptive immune dysfunction. Int J Mol Sci 21(10):3422","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4750_CR77","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3390\/ijms24021526","volume":"24","author":"A Saez","year":"2023","unstructured":"Saez A, Herrero-Fernandez B, Gomez-Bris R, S\u00e1nchez-Martinez H, Gonzalez-Granado JM (2023) Pathophysiology of inflammatory bowel disease: innate immune system. Int J Mol Sci 24(2):1526","journal-title":"Int J Mol Sci"},{"key":"4750_CR78","doi-asserted-by":"crossref","first-page":"577801","DOI":"10.1016\/j.jneuroim.2021.577801","volume":"363","author":"J Dhankhar","year":"2022","unstructured":"Dhankhar J, Agrawal N, Shrivastava A (2022) Pan-neuronal expression of human mutant huntingtin protein in Drosophila impairs immune response of hemocytes. J Neuroimmunol 363:577801","journal-title":"J Neuroimmunol"},{"key":"4750_CR79","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.3389\/fimmu.2019.02405","volume":"10","author":"Y-H Lin","year":"2019","unstructured":"Lin Y-H, Maaroufi HO, Ibrahim E, Kucerova L, Zurovec M (2019) Expression of human mutant huntingtin protein in Drosophila hemocytes impairs immune responses. Front Immunol 10:2405","journal-title":"Front Immunol"},{"issue":"4","key":"4750_CR80","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1021\/acs.jnatprod.1c01231","volume":"85","author":"X Chen","year":"2022","unstructured":"Chen X, Wu Q, Gong Z, Ren T, Du Q, Yuan Y, Zuo Y, Miao Y et al (2022) A natural plant ingredient, menthone, regulates T cell subtypes and lowers pro-inflammatory cytokines of rheumatoid arthritis. J Nat Prod 85(4):1109\u20131117","journal-title":"J Nat Prod"},{"key":"4750_CR81","doi-asserted-by":"crossref","first-page":"1034420","DOI":"10.3389\/fimmu.2022.1034420","volume":"13","author":"PP Mulder","year":"2022","unstructured":"Mulder PP, Vlig M, Fasse E, Stoop MM, Pijpe A, van Zuijlen PP, Joosten I, Boekema BK et al (2022) Burn-injured skin is marked by a prolonged local acute inflammatory response of innate immune cells and pro-inflammatory cytokines. Front Immunol 13:1034420","journal-title":"Front Immunol"},{"issue":"1","key":"4750_CR82","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/ijms24010132","volume":"24","author":"X Yang","year":"2022","unstructured":"Yang X, Tian Y, Zheng L, Luu T, Kwak-Kim J (2022) The update immune-regulatory role of pro-and anti-inflammatory cytokines in recurrent pregnancy losses. Int J Mol Sci 24(1):132","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4750_CR83","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jcp.21993","volume":"222","author":"AF Olena","year":"2010","unstructured":"Olena AF, Patton JG (2010) Genomic organization of microRNAs. J Cell Physiol 222(3):540\u2013545","journal-title":"J Cell Physiol"},{"issue":"10a","key":"4750_CR84","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1101\/gr.2722704","volume":"14","author":"A Rodriguez","year":"2004","unstructured":"Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A (2004) Identification of mammalian microRNA host genes and transcription units. Genome Res 14(10a):1902\u20131910","journal-title":"Genome Res"},{"issue":"7014","key":"4750_CR85","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature03049","volume":"432","author":"AM Denli","year":"2004","unstructured":"Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ (2004) Processing of primary microRNAs by the Microprocessor complex. Nature 432(7014):231\u2013235","journal-title":"Nature"},{"key":"4750_CR86","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.mito.2022.08.002","volume":"66","author":"E Erturk","year":"2022","unstructured":"Erturk E, Onur OE, Akgun O, Tuna GP, Yildiz Y, Ari F (2022) Mitochondrial miRNAs (MitomiRs): their potential roles in breast and other cancers. Mitochondrion 66:74\u201381","journal-title":"Mitochondrion"},{"issue":"10","key":"4750_CR87","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41477-021-01000-1","volume":"7","author":"X Wei","year":"2021","unstructured":"Wei X, Ke H, Wen A, Gao B, Shi J, Feng Y (2021) Structural basis of microRNA processing by Dicer-like 1. Nat Plants 7(10):1389\u20131396","journal-title":"Nat Plants"},{"issue":"11","key":"4750_CR88","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1101\/gad.1919710","volume":"24","author":"MA Newman","year":"2010","unstructured":"Newman MA, Hammond SM (2010) Emerging paradigms of regulated microRNA processing. Genes Dev 24(11):1086\u20131092","journal-title":"Genes Dev"},{"issue":"12","key":"4750_CR89","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","volume":"24","author":"R Shang","year":"2023","unstructured":"Shang R, Lee S, Senavirathne G, Lai EC (2023) microRNAs in action: biogenesis, function and regulation. Nat Rev Genet 24(12):816\u2013833","journal-title":"Nat Rev Genet"},{"key":"4750_CR90","first-page":"1","volume":"2257","author":"K Ergin","year":"2022","unstructured":"Ergin K, \u00c7etinkaya R (2022) Regulation of microRNAs, miRNomics. Springer 2257:1\u201332","journal-title":"Springer"},{"issue":"7149","key":"4750_CR91","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature05983","volume":"448","author":"JG Ruby","year":"2007","unstructured":"Ruby JG, Jan CH, Bartel DP (2007) Intronic microRNA precursors that bypass Drosha processing. Nature 448(7149):83\u201386","journal-title":"Nature"},{"issue":"20","key":"4750_CR92","first-page":"2773","volume":"22","author":"JE Babiarz","year":"2008","unstructured":"Babiarz JE, Ruby JG, Wang Y, Bartel DP, Blelloch R (2008) Mouse ES cells express endogenous shRNAs, siRNAs, and other microprocessor-independent. Dicer-dependent small RNAs, Genes Dev 22(20):2773\u20132785","journal-title":"Dicer-dependent small RNAs, Genes Dev"},{"key":"4750_CR93","first-page":"402","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C (2018) Overview of MicroRNA biogenesis. Mech Act Cir 9:402","journal-title":"Mech Act Cir"},{"issue":"1","key":"4750_CR94","first-page":"15","volume":"2014","author":"A Valinezhad Orang","year":"2014","unstructured":"Valinezhad Orang A, Safaralizadeh R, Kazemzadeh-Bavili M (2014) Mechanisms of miRNA-mediated gene regulation from common downregulation to mRNA-specific upregulation. Int J Genomics 2014(1):15","journal-title":"Int J Genomics"},{"issue":"10","key":"4750_CR95","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3390\/ijms17101712","volume":"17","author":"C Catalanotto","year":"2016","unstructured":"Catalanotto C, Cogoni C, Zardo G (2016) MicroRNA in control of gene expression: An overview of nuclear functions. Int J Mol Sci 17(10):1712. https:\/\/doi.org\/10.3390\/ijms17101712","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4750_CR96","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/cells9020276","volume":"9","author":"CE Condrat","year":"2020","unstructured":"Condrat CE, Thompson DC, Barbu MG, Bugnar OL, Boboc A, Cretoiu D, Suciu N, Cretoiu SM et al (2020) miRNAs as biomarkers in disease: Latest findings regarding their role in diagnosis and prognosis. Cells 9(2):276. https:\/\/doi.org\/10.3390\/cells9020276","journal-title":"Cells"},{"issue":"7","key":"4750_CR97","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1134\/S0006297921070014","volume":"86","author":"EV Semina","year":"2021","unstructured":"Semina EV, Rysenkova KD, Troyanovskiy KE, Shmakova AA, Rubina KA (2021) MicroRNAs in cancer: From gene expression regulation to the metastatic niche reprogramming. Biochem Mosc 86(7):785\u2013799","journal-title":"Biochem Mosc"},{"key":"4750_CR98","doi-asserted-by":"crossref","first-page":"101664","DOI":"10.1016\/j.pneurobio.2019.101664","volume":"182","author":"CA Ju\u017awik","year":"2019","unstructured":"Ju\u017awik CA, Drake SS, Zhang Y, Paradis-Isler N, Sylvester A, Amar-Zifkin A, Douglas C, Morquette B et al (2019) microRNA dysregulation in neurodegenerative diseases: A systematic review. Prog Neurobiology 182:101664","journal-title":"Prog Neurobiology"},{"issue":"6","key":"4750_CR99","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.celrep.2018.07.017","volume":"24","author":"K Pircs","year":"2018","unstructured":"Pircs K, Petri R, Madsen S, Bratt\u00e5s PL, Vuono R, Ottosson DR, St-Amour I, Hersbach BA et al (2018) Huntingtin aggregation impairs autophagy, leading to argonaute-2 accumulation and global MicroRNA dysregulation. Cell Rep 24(6):1397\u20131406","journal-title":"Cell Rep"},{"issue":"1","key":"4750_CR100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12929-021-00755-1","volume":"28","author":"C-W Tung","year":"2021","unstructured":"Tung C-W, Huang P-Y, Chan SC, Cheng P-H, Yang S-H (2021) The regulatory roles of microRNAs toward pathogenesis and treatments in Huntington\u2019s disease. J Biomed Sci 28(1):59","journal-title":"J Biomed Sci"},{"issue":"10","key":"4750_CR101","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","volume":"16","author":"SJ Tabrizi","year":"2020","unstructured":"Tabrizi SJ, Flower MD, Ross CA, Wild EJ (2020) Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat Rev Neurol 16(10):529\u2013546","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"4750_CR102","doi-asserted-by":"crossref","first-page":"e1004188","DOI":"10.1371\/journal.pgen.1004188","volume":"10","author":"AG Hoss","year":"2014","unstructured":"Hoss AG, Kartha VK, Dong X, Latourelle JC, Dumitriu A, Hadzi TC, MacDonald ME, Gusella JF et al (2014) MicroRNAs Located in the Hox Gene Clusters Are Implicated in Huntington\u2019s Disease Pathogenesis. PLoS Genet 10(2):e1004188","journal-title":"PLoS Genet"},{"issue":"12","key":"4750_CR103","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/embor.2010.182","volume":"11","author":"S Humbert","year":"2010","unstructured":"Humbert S (2010) Is Huntington disease a developmental disorder? EMBO Rep 11(12):899\u2013899","journal-title":"EMBO Rep"},{"issue":"1","key":"4750_CR104","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s40478-022-01407-7","volume":"10","author":"S Petry","year":"2022","unstructured":"Petry S, Keraudren R, Nateghi B, Loiselle A, Pircs K, Jakobsson J, Sephton C, Langlois M et al (2022) Widespread alterations in microRNA biogenesis in human Huntington\u2019s disease putamen. Acta Neuropathol Commun 10(1):106","journal-title":"Acta Neuropathol Commun"},{"key":"4750_CR105","doi-asserted-by":"crossref","unstructured":"R\u00fcb U, Vonsattel JPG, Heinsen H, Korf HW (2015) The neuropathology of Huntington\u2019s disease: classical findings, recent developments and correlation to functional neuroanatomy. Springer Book pp 1\u2013145","DOI":"10.1007\/978-3-319-19285-7_1"},{"issue":"10","key":"4750_CR106","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41593-018-0237-7","volume":"21","author":"L Gan","year":"2018","unstructured":"Gan L, Cookson MR, Petrucelli L, La Spada AR (2018) Converging pathways in neurodegeneration, from genetics to mechanisms. Nat Neurosci 21(10):1300\u20131309","journal-title":"Nat Neurosci"},{"issue":"20","key":"4750_CR107","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1093\/nar\/gkq575","volume":"38","author":"E Mart\u00ed","year":"2010","unstructured":"Mart\u00ed E, Pantano L, Banez-Coronel M, Llorens F, Minones-Moyano E, Porta S, Sumoy L, Ferrer I et al (2010) A myriad of miRNA variants in control and Huntington\u2019s disease brain regions detected by massively parallel sequencing. Nucleic Acids Res 38(20):7219\u20137235","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4750_CR108","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1756-6606-7-46","volume":"7","author":"J Kocerha","year":"2014","unstructured":"Kocerha J, Xu Y, Prucha MS, Zhao D, Chan AWS (2014) microRNA-128a dysregulation in transgenic Huntington\u2019s disease monkeys. Mol Brain 7(1):46","journal-title":"Mol Brain"},{"issue":"6163","key":"4750_CR109","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.1244193","volume":"342","author":"CL Tan","year":"2013","unstructured":"Tan CL, Plotkin JL, Ven\u00f8 MT, Von Schimmelmann M, Feinberg P, Mann S, Handler A, Kjems J et al (2013) MicroRNA-128 governs neuronal excitability and motor behavior in mice. Science 342(6163):1254\u20131258","journal-title":"Science"},{"issue":"14","key":"4750_CR110","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/mds.25237","volume":"27","author":"LJ Cloud","year":"2012","unstructured":"Cloud LJ, Rosenblatt A, Margolis RL, Ross CA, Pillai JA, Corey-Bloom J, Tully HM, Bird T et al (2012) Seizures in juvenile Huntington\u2019s disease: frequency and characterization in a multicenter cohort. Mov Disord 27(14):1797\u20131800","journal-title":"Mov Disord"},{"issue":"1","key":"4750_CR111","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/mds.28823","volume":"37","author":"HS Bakels","year":"2022","unstructured":"Bakels HS, Roos RA, van Roon-Mom WM, de Bot ST (2022) Juvenile-onset Huntington disease pathophysiology and neurodevelopment: a review. Mov Disord 37(1):16\u201324","journal-title":"Mov Disord"},{"issue":"10","key":"4750_CR112","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1073\/pnas.0611625104","volume":"104","author":"I Gantois","year":"2007","unstructured":"Gantois I, Fang K, Jiang L, Babovic D, Lawrence AJ, Ferreri V, Teper Y, Jupp B et al (2007) Ablation of D1 dopamine receptor-expressing cells generates mice with seizures, dystonia, hyperactivity, and impaired oral behavior. Proc Natl Acad Sci 104(10):4182\u20134187","journal-title":"Proc Natl Acad Sci"},{"key":"4750_CR113","first-page":"1","volume":"2595","author":"A Vishnoi","year":"2022","unstructured":"Vishnoi A, Rani S (2022) miRNA biogenesis and regulation of diseases: an updated overview. MicroRNA Profiling: Methods and Protocols 2595:1\u201312","journal-title":"MicroRNA Profiling: Methods and Protocols"},{"key":"4750_CR114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-6524-3_1","volume":"1509","author":"A Vishnoi","year":"2017","unstructured":"Vishnoi A, Rani S (2017) MiRNA biogenesis and regulation of diseases: an overview. MicroRNA profiling: Methods and protocols 1509:1\u201310","journal-title":"MicroRNA profiling: Methods and protocols"},{"key":"4750_CR115","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s12035-015-9145-y","volume":"53","author":"L Shamsuzzama","year":"2016","unstructured":"Shamsuzzama L, Kumar R, Haque A (2016) Nazir, Role of microRNA Let-7 in modulating multifactorial aspect of neurodegenerative diseases: an overview. Mol Neurobiol 53:2787\u20132793","journal-title":"Mol Neurobiol"},{"issue":"16","key":"4750_CR116","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1093\/hmg\/ddaa184","volume":"29","author":"GEB Wright","year":"2020","unstructured":"Wright GEB, Caron NS, Ng B, Casal L, Casazza W, Xu X, Ooi J, Pouladi MA et al (2020) Gene expression profiles complement the analysis of genomic modifiers of the clinical onset of Huntington disease. Hum Mol Genet 29(16):2788\u20132802","journal-title":"Hum Mol Genet"},{"issue":"12","key":"4750_CR117","doi-asserted-by":"crossref","first-page":"19245","DOI":"10.1002\/jcb.29268","volume":"120","author":"A Soleimani","year":"2019","unstructured":"Soleimani A, Rahmani F, Saeedi N, Ghaffarian R, Khazaei M, Ferns GA, Avan A, Hassanian SM (2019) The potential role of regulatory microRNAs of RAS\/MAPK signaling pathway in the pathogenesis of colorectal cancer. J Cell Biochem 120(12):19245\u201319253","journal-title":"J Cell Biochem"},{"issue":"5","key":"4750_CR118","doi-asserted-by":"crossref","first-page":"e13475","DOI":"10.1111\/aji.13475","volume":"86","author":"MA Zolfaghari","year":"2021","unstructured":"Zolfaghari MA, Arefnezhad R, Parhizkar F, Hejazi MS, Motavalli Khiavi F, Mahmoodpoor A, Yousefi M (2021) T lymphocytes and preeclampsia: the potential role of T-cell subsets and related MicroRNAs in the pathogenesis of preeclampsia. Am J Repro Immu 86(5):e13475","journal-title":"Am J Repro Immu"},{"issue":"2","key":"4750_CR119","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3390\/ijms19020599","volume":"19","author":"S Agrawal","year":"2018","unstructured":"Agrawal S, Tapmeier TT, Rahmioglu N, Kirtley S, Zondervan KT, Becker CM (2018) The miRNA mirage: how close are we to finding a non-invasive diagnostic biomarker in endometriosis? A systematic review. Int J Mol Sci 19(2):599","journal-title":"Int J Mol Sci"},{"issue":"16","key":"4750_CR120","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.7150\/thno.31502","volume":"9","author":"E Prieto-Fern\u00e1ndez","year":"2019","unstructured":"Prieto-Fern\u00e1ndez E, Aransay AM, Royo F, Gonz\u00e1lez E, Lozano JJ, Santos-Zorrozua B, Macias-Camara N, Gonz\u00e1lez M et al (2019) A comprehensive study of vesicular and non-vesicular miRNAs from a volume of cerebrospinal fluid compatible with clinical practice. Theranostics 9(16):4567","journal-title":"Theranostics"},{"key":"4750_CR121","first-page":"1","volume":"5","author":"S Nagaraj","year":"2017","unstructured":"Nagaraj S (2017) Pros and cons of miRNAs as non-invasive circulatory biomarkers. Res Rev Res J Biol 5:1\u20137","journal-title":"Res Rev Res J Biol"},{"issue":"1","key":"4750_CR122","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10565-022-09761-x","volume":"39","author":"S Li","year":"2023","unstructured":"Li S, Lei Z, Sun T (2023) The role of microRNAs in neurodegenerative diseases: a review. Cell Biol Toxicol 39(1):53\u201383","journal-title":"Cell Biol Toxicol"},{"issue":"53","key":"4750_CR123","doi-asserted-by":"crossref","first-page":"14341","DOI":"10.1523\/JNEUROSCI.2390-08.2008","volume":"28","author":"AN Packer","year":"2008","unstructured":"Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL (2008) The bifunctional microRNA miR-9\/miR-9* regulates REST and CoREST and is downregulated in Huntington\u2019s disease. J Neurosci 28(53):14341\u201314346","journal-title":"J Neurosci"},{"issue":"11","key":"4750_CR124","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/hmg\/ddr111","volume":"20","author":"PM Gaughwin","year":"2011","unstructured":"Gaughwin PM, Ciesla M, Lahiri N, Tabrizi SJ, Brundin P, Bj\u00f6rkqvist M (2011) Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington\u2019s disease. Hum Mol Genet 20(11):2225\u20132237","journal-title":"Hum Mol Genet"},{"key":"4750_CR125","doi-asserted-by":"crossref","unstructured":"Yadava P, Mukherjee SK (2012) Artificial microRNA and its applications, Regulatory RNAs: basics. Meth Appli Springer Book pp 505\u2013521","DOI":"10.1007\/978-3-642-22517-8_20"},{"key":"4750_CR126","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.omtm.2019.03.002","volume":"13","author":"EA Spronck","year":"2019","unstructured":"Spronck EA, Brouwers CC, Vall\u00e8s A, de Haan M, Petry H, van Deventer SJ, Konstantinova P, Evers MM (2019) AAV5-miHTT gene therapy demonstrates sustained huntingtin lowering and functional improvement in Huntington disease mouse models. Molecular Therapy-Methods & Clinical Development 13:334\u2013343","journal-title":"Molecular Therapy-Methods & Clinical Development"},{"key":"4750_CR127","doi-asserted-by":"crossref","unstructured":"J. Miniarikova, I. Zanella, A. Huseinovic, T. van der Zon, E. Hanemaaijer, R. Martier, A. Koornneef, A.L. Southwell, M.R. Hayden, S.J. van Deventer, Design, characterization, and lead selection of therapeutic miRNAs targeting huntingtin for development of gene therapy for Huntington\u2019s disease, Molecular Therapy-Nucleic Acids 5 (2016).","DOI":"10.1038\/mtna.2016.7"},{"issue":"1","key":"4750_CR128","first-page":"36","volume":"48","author":"NS Caron","year":"2020","unstructured":"Caron NS, Southwell AL, Brouwers CC, Cengio LD, Xie Y, Black HF, Anderson LM, Ko S et al (2020) Potent and sustained huntingtin lowering via AAV5 encoding miRNA preserves striatal volume and cognitive function in a humanized mouse model of Huntington disease. Nucleic Acids Res 48(1):36\u201354","journal-title":"Nucleic Acids Res"},{"key":"4750_CR129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-016-0551-7","volume":"12","author":"K-H Chang","year":"2017","unstructured":"Chang K-H, Wu Y-R, Chen C-M (2017) Down-regulation of miR-9* in the peripheral leukocytes of Huntington\u2019s disease patients. Orphanet J Rare Dis 12:1\u20135","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"4750_CR130","first-page":"e264","volume":"90","author":"ER Reed","year":"2018","unstructured":"Reed ER, Latourelle JC, Bockholt JH, Bregu J, Smock J, Paulsen JS, Myers RH (2018) P.-H.C.a.s. investigators, P.-H.C.a.s. investigators, MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study. Neurology 90(4):e264\u2013e272","journal-title":"Neurology"},{"issue":"5","key":"4750_CR131","doi-asserted-by":"crossref","first-page":"786","DOI":"10.4103\/1673-5374.156978","volume":"10","author":"T Liu","year":"2015","unstructured":"Liu T, Im W, Mook-Jung I, Kim M (2015) MicroRNA-124 slows down the progression of Huntington\u2019s disease by promoting neurogenesis in the striatum. Neural Regen Res 10(5):786\u2013791","journal-title":"Neural Regen Res"},{"issue":"1","key":"4750_CR132","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s10020-023-00640-7","volume":"29","author":"M Hart","year":"2023","unstructured":"Hart M, Diener C, Lunkes L, Rheinheimer S, Krammes L, Keller A, Meese E (2023) miR-34a-5p as molecular hub of pathomechanisms in Huntington\u2019s disease. Mol Med 29(1):43","journal-title":"Mol Med"},{"issue":"2","key":"4750_CR133","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.bbrc.2017.05.040","volume":"488","author":"J-J Ban","year":"2017","unstructured":"Ban J-J, Chung J-Y, Lee M, Im W, Kim M (2017) MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington\u2019s disease. Biochem Biophys Res Commun 488(2):316\u2013321","journal-title":"Biochem Biophys Res Commun"},{"key":"4750_CR134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-6606-7-46","volume":"7","author":"J Kocerha","year":"2014","unstructured":"Kocerha J, Xu Y, Prucha MS, Zhao D, Chan AWS (2014) microRNA-128a dysregulation in transgenic Huntington\u2019s disease monkeys. Mol Brain 7:1\u201310","journal-title":"Mol Brain"},{"issue":"2","key":"4750_CR135","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ajhg.2013.05.025","volume":"93","author":"P-H Cheng","year":"2013","unstructured":"Cheng P-H, Li C-L, Chang Y-F, Tsai S-J, Lai Y-Y, Chan AWS, Chen C-M, Yang S-H (2013) miR-196a ameliorates phenotypes of Huntington disease in cell, transgenic mouse, and induced pluripotent stem cell models. The American Journal of Human Genetics 93(2):306\u2013312","journal-title":"The American Journal of Human Genetics"},{"issue":"17","key":"4750_CR136","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3390\/cells12172155","volume":"12","author":"CFM Vasconcelos","year":"2023","unstructured":"Vasconcelos CFM, Ribas VT, Petrs-Silva H (2023) Shared molecular pathways in glaucoma and other neurodegenerative diseases: Insights from RNA-Seq analysis and miRNA regulation for promising therapeutic avenues. Cells 12(17):2155","journal-title":"Cells"},{"issue":"4","key":"4750_CR137","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ncrna.2023.10.002","volume":"8","author":"I Gareev","year":"2023","unstructured":"Gareev I, Beylerli O, Rasim T, Ilyasova T, Shumadalova A, Du W, Yang B (2023) Methods of miRNA delivery and possibilities of their application in neuro-oncology. Non-coding RNA Research 8(4):661\u2013674","journal-title":"Non-coding RNA Research"},{"issue":"1","key":"4750_CR138","doi-asserted-by":"crossref","first-page":"237","DOI":"10.21873\/anticanres.13103","volume":"39","author":"BO Yuan","year":"2019","unstructured":"Yuan BO, Zhao Y, Dong S, Sun Y, Hao FEI, Xie J, Teng L, Lee RJ et al (2019) Cell-penetrating peptide-coated liposomes for drug delivery across the blood\u2013brain barrier. Anticancer Res 39(1):237\u2013243","journal-title":"Anticancer Res"},{"key":"4750_CR139","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1227\/01.neu.0000489858.08559.c8","volume":"63","author":"RA Vega","year":"2016","unstructured":"Vega RA, Zhang Y, Curley C, Price RL, Abounader R (2016) 370 magnetic resonance-guided focused ultrasound delivery of polymeric brain-penetrating nanoparticle microRNA conjugates in glioblastoma. Neurosurgery 63:210","journal-title":"Neurosurgery"},{"key":"4750_CR140","doi-asserted-by":"crossref","first-page":"673415","DOI":"10.3389\/fbioe.2021.673415","volume":"9","author":"J Wang","year":"2021","unstructured":"Wang J, Xu F, Zhu X, Li X, Li Y, Li J (2021) Targeting microRNAs to regulate the integrity of the blood\u2013brain barrier. Frontiers in Bioengineering and Biotechnology 9:673415","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"6","key":"4750_CR141","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/pharmaceutics12060542","volume":"12","author":"MI Teixeira","year":"2020","unstructured":"Teixeira MI, Amaral MH, Costa PC, Lopes CM, Lamprou DA (2020) Recent developments in microfluidic technologies for central nervous system targeted studies. Pharmaceutics 12(6):542","journal-title":"Pharmaceutics"},{"issue":"6","key":"4750_CR142","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40259-018-0309-y","volume":"32","author":"DB Stanimirovic","year":"2018","unstructured":"Stanimirovic DB, Sandhu JK, Costain WJ (2018) Emerging technologies for delivery of biotherapeutics and gene therapy across the blood\u2013brain barrier. BioDrugs 32(6):547\u2013559","journal-title":"BioDrugs"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04750-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04750-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04750-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:02:41Z","timestamp":1751382161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04750-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":142,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["4750"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04750-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"17 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}